The ever-present risk of importing dog rabiesSeptember 23, 2021Does your clinic routinely ask about your patients’ travel history and review their vaccination records?
SPONSORED CONTENTHelp save more lives with this parvovirus innovationOur Canine Parvovirus Monoclonal Antibody offered a 93% real-world survival rate for puppies afflicted with parvovirus.1 Discover the future of parvo treatment today! + Read More
Give it your best shot to improve vaccine complianceSeptember 1, 2021The reasons pet owners give for not getting their pets vaccinated are varied, and often deeply personal.
Vaccine questions and resistanceJune 2, 2021Veterinarians probably have more familiarity with the science and application of vaccines than most physicians, excepting pediatricians. We understand the science of vaccines, the potential risks, and all the issues around immunization that are so hotly debated in the media these days.
Can old vaccines reveal new secrets?June 2, 2020The COVID-19 pandemic has brought the return of a period many of us have never experienced—a time before vaccines, when medicine had little power to stop the spread of infectious diseases.
Is a heartworm vaccine on the horizon?May 21, 2020Protecting dogs from deadly parasites and combating drug resistance to heartworm medications are the central goals behind a new Morris Animal Foundation-funded study. Â Â
Biopharma company partners to make oral COVID-19 vaccineMay 20, 2020A vaccination tablet for the novel coronavirus might soon be available, thanks to a new partnership between KindredBiosciences and Vaxart.
COVID-19 research underway in LouisianaMarch 11, 2020Researchers at Louisiana State University School of Veterinary Medicine (LSU SVM) are hoping to develop a vaccine that could be used to prevent novel coronavirus (COVID-19) infection in humans.
Do your vaccine conversations need a makeover?March 6, 2020Clients want specific advice on which vaccines their pets need to stay protected. Too often, your team may use wiggle words that could put pets at risk.
Boehringer Ingelheim completes $76-million expansionOctober 14, 2019Boehringer Ingelheim revealed a $76-million expansion at its manufacturing plant in Athens, Ga., that will double the company’s capacity to produce vaccines for pets.
Boehringer donates 60,000 rabies vaccines to Puerto RicoSeptember 27, 2019Residents of Puerto Rico will soon be better protected from rabies transmission, thanks to Boehringer Ingelheim.
